Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic Etoricoxib 120 mg vs ACOXIA in Healthy Thai Volunteers under Fasting Conditions
TCTR20180525002Phase 3Not yet recruiting
- Sponsor
- Pond Chemical
- Start
- Aug 2018
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Pond Chemical. Primary endpoint: Primary pharmacokinetic bioequivalence. Planned start Aug 2018; status: not yet recruiting.
Beyond the preview
Go deeper on TCTR20180525002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180525002.